Detailed epitope mapping of SARS-CoV-2 nucleoprotein reveals specific immunoresponse in cats and dogs housed with COVID-19 patients. 2022

Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
Department of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Torino, Italy. Electronic address: barbara.colitti@unito.it.

Since the initial emergence in December 2019, the novel Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been reported in over 200 countries, representing an unprecedented challenge related to disease control worldwide. In this context, cases of human to animal transmission have been reported, raising concern about the potential role of companion animals in the pandemic and stressing the need for reliable animal testing. In the study, a detailed epitope mapping of SARS-CoV-2 nucleoprotein, using both human and pet sera, allowed the identification of the most antigenic region in the C-terminus domain of the protein, which was used to develop an experimental double antigen-based ELISA. A panel of pre-pandemic sera and sera of animals immunized against (or naturally infected with) related coronaviruses was used to assess assay specificity at 99.5%. Positive sera belonging to animals housed with COVID-19 patients were confirmed with the experimental double-antigen ELISA using Plaque Reduction Neutralization test (PRNT) test as gold standard. The availability of a serological assay that targets a highly specific viral antigen represents a valuable tool for multispecies monitoring of Coronavirus Disease 2019 (COVID-19) infection in susceptible animals.

UI MeSH Term Description Entries
D010750 Phosphoproteins Phosphoprotein
D002371 Cat Diseases Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used. Feline Diseases,Cat Disease,Disease, Cat,Disease, Feline,Diseases, Cat,Diseases, Feline,Feline Disease
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000086462 Coronavirus Nucleocapsid Proteins Nucleocapsid proteins from species of the CORONAVIRIDAE virus family. N Protein, Coronavirus,Nucleocapsid Protein, Coronavirus,Coronavirus N Protein,Coronavirus Nucleocapsid Protein,Nucleocapsid Proteins, Coronavirus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
January 2021, Frontiers in immunology,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
April 2021, Science immunology,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
January 2021, Frontiers in immunology,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
December 2021, Virulence,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
December 2021, Emerging infectious diseases,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
January 2021, Signal transduction and targeted therapy,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
January 2021, International immunopharmacology,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
November 2021, Communications biology,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
January 2023, Memorias do Instituto Oswaldo Cruz,
Barbara Colitti, and Francesco Bonfante, and Santina Grazioli, and Laura Anfossi, and Chiara Nogarol, and Daniela Scalas, and Luigi Bertolotti, and Alessio Bortolami, and Matteo Pagliari, and Giulia Pezzoni, and Ana Moreno, and Davide Lelli, and Maria Silvia Gennero, and Alessandro Dondo, and Emiliana Brocchi, and Sergio Rosati
November 2022, Transboundary and emerging diseases,
Copied contents to your clipboard!